Cisco Systems Inc. sold $13.5 billion of bonds in the U.S. investment-grade debt market to partly finance its proposed $28 billion acquisition of Splunk Inc.
The sale is the latest sign that investors are willing to buy bonds that help fund acquisitions, a form of debt they largely avoided for much of the last year. Last week Bristol Myers Squibb sold $13 billion of bonds to help finance two of acquisitions, an offering that gathered orders exceeding $85 billion.
Biotech giant AbbVie Inc., which agreed in November to buy ImmunoGen Inc. for a total equity value of $10.1 billion, is also looking at selling bonds. It asked a group of banks—including Morgan Stanley, JPMorgan Chase & Co., Bank of America, and Citigroup Inc.—to arrange a series of calls with fixed-income investors on Wednesday.
Continue Reading for Free
Register and gain access to:
- Thought leadership on regulatory changes, economic trends, corporate success stories, and tactical solutions for treasurers, CFOs, risk managers, controllers, and other finance professionals
- Informative weekly newsletter featuring news, analysis, real-world cas studies, and other critical content
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
